AquaBounty Technologies, Inc. (NASDAQ:AQB) Short Interest Update
by Amy Steele · The Cerbat GemAquaBounty Technologies, Inc. (NASDAQ:AQB – Get Free Report) was the target of a significant decrease in short interest in December. As of December 15th, there was short interest totaling 11,813 shares, a decrease of 48.8% from the November 30th total of 23,090 shares. Approximately 0.3% of the shares of the stock are sold short. Based on an average daily trading volume, of 22,365 shares, the days-to-cover ratio is presently 0.5 days. Based on an average daily trading volume, of 22,365 shares, the days-to-cover ratio is presently 0.5 days. Approximately 0.3% of the shares of the stock are sold short.
Analysts Set New Price Targets
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of AquaBounty Technologies in a research report on Monday, December 22nd. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.
Read Our Latest Stock Analysis on AQB
Institutional Trading of AquaBounty Technologies
A hedge fund recently bought a new stake in AquaBounty Technologies stock. Two Sigma Investments LP acquired a new position in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 37,565 shares of the company’s stock, valued at approximately $84,000. Two Sigma Investments LP owned about 0.97% of AquaBounty Technologies at the end of the most recent quarter. Institutional investors and hedge funds own 8.92% of the company’s stock.
AquaBounty Technologies Stock Up 20.4%
Shares of AQB stock traded up $0.17 during mid-day trading on Friday, reaching $1.02. 211,323 shares of the stock traded hands, compared to its average volume of 26,124. The stock’s fifty day simple moving average is $1.07 and its two-hundred day simple moving average is $1.09. AquaBounty Technologies has a 1-year low of $0.50 and a 1-year high of $2.95. The company has a market cap of $3.96 million, a price-to-earnings ratio of -1.23 and a beta of 1.36.
AquaBounty Technologies (NASDAQ:AQB – Get Free Report) last announced its quarterly earnings results on Tuesday, October 28th. The company reported ($0.36) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.62) by $0.26.
About AquaBounty Technologies
AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.
Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.